Oncolytics Biotech (ONCY) Operating Expenses (2009 - 2026)
Oncolytics Biotech (ONCY) recorded Operating Expenses of $9.38 million in Q2 2026, up 101.7% from $4.65 million a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Operating Expenses (2009 - 2026) Analysis & Trends
On a TTM basis, Oncolytics Biotech's Operating Expenses came in at $37.39 million as of Jun 30, 2026, up 63.8% year-over-year; for FY2025, it came in at $28.73 million, up 12.5% from FY2024.
- Annual Operating Expenses has increased for three straight years, with a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
- Across earlier years, Operating Expenses came in at $25.54 million in FY2024 (+2.0%), $25.04 million in FY2023 (+183.3%), $8.84 million in FY2022 (-16.8%) and $10.62 million in FY2021 (+13.7%).
- Quarterly Operating Expenses has ranged from $4.65 million in Q3 2022 to $13.3 million in Q4 2025 over the past five years.
- On a year-over-year basis, Operating Expenses rose in three of the last seven quarters, with growth averaging 28.2%.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 128.5% in Q1 2022, against a decline of 24.7% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 15.99 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 11.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 11.14 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.53 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.00 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 6.66 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.84 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.09 Bn |
| 10 | Oncolytics Biotech | 47.36 Mn | 23.68 Mn | - | 9.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.38 Mn |
| Mar 31, 2026 | 9.28 Mn |
| Sep 30, 2025 | 10.07 Mn |
| Jun 30, 2025 | 4.65 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 6.04 Mn |
| Sep 30, 2024 | 7.28 Mn |
| Jun 30, 2024 | 5.79 Mn |
| Mar 31, 2024 | 6.48 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 8.24 Mn |
| Jun 30, 2023 | 5.33 Mn |
| Mar 31, 2023 | 4.98 Mn |
| Dec 31, 2022 | 6.27 Mn |
| Sep 30, 2022 | 4.65 Mn |
| Jun 30, 2022 | 2.23 Mn |
| Mar 31, 2022 | 2.05 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 2.28 Mn |
| Jun 30, 2021 | 2.86 Mn |
API Access
Oncolytics Biotech Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();